The Scottish Medicines Consortium has announced its latest decisions on what new drugs can be used by the NHS in Scotland.

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

Discover a study where patients reported a high severity of treatment side effects than anticipated by their clinicians.

Durvalumab plus full BCG significantly improved disease-free survival in high-risk early bladder cancer vs BCG alone in the ...

Bill Russell and Jim Rieker are survivors. Both diagnosed with bladder cancer, the men have made it their mission to help ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

cretostimogene grenadenorepvec may be a much-needed advancement in the bladder cancer treatment paradigm that could help thousands of patients avoid surgery. Complete removal of the bladder is a ...

1 TO 2 WEEKS OR SHORTER. HAVE THERE BEEN ANY ADVANCEMENTS WHEN IT COMES TO DIAGNOSING OR TREATMENTS IN TERMS OF DETECTION FOR BLADDER CANCER, THERE IS NO MOLECULAR TESTING THAT YOU COULD RUN ON A ...

A new jab which allows cancer patients to be treated with just one injection is set to be rolled out by the NHS for 15 ...